Literature DB >> 23751897

Puerarin, isolated from Kudzu root (Willd.), attenuates hepatocellular cytotoxicity and regulates the GSK-3β/NF-κB pathway for exerting the hepatoprotection against chronic alcohol-induced liver injury in rats.

Rong Li1, Tao Liang, Qiaoling He, Chao Guo, Lingyuan Xu, Kefeng Zhang, Xiaoqun Duan.   

Abstract

Puerarin (PR) has been utilized as a phytomedicine to managing liver disease in China. Thus, this study aimed to evaluate the potential PR-mediated hepatoprotective role against chronic alcohol-induced liver injury in rats. The results indicated that serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and pro-inflammatory cytokines were significantly reduced following PR treatment, while the albumin (ALB) level was increased. Meanwhile, intrahepatic contents of alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH) were elevated. Pathological examination showed that alcohol-lesioned hepatocytes were mitigated through the PR treatment. In addition, the endogenous levels of glycogen synthase kinase-3β (GSK-3β) at the protein level and β-catenin expression at the mRNA level were notably down-regulated, whereas the tumor necrosis factor alpha (TNF-α) and nuclear factor-kappa B (NF-κB) proteins in the liver tissue were effectively decreased following the PR treatment. Together, these findings demonstrate that PR mediates hepatoprotection against alcohol-induced liver injury. The mechanisms underlying the cytoprotective effects of PR are associated with inhibiting immunotoxicity in hepatocytes and regulating the GSK-3β/NF-κB pathway, thereby maintaining metabolic homeostasis in the liver tissue.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol; GSK-3β/NF-κB pathway; Immunotoxicity; Liver injury; Puerarin

Mesh:

Substances:

Year:  2013        PMID: 23751897     DOI: 10.1016/j.intimp.2013.05.023

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  9 in total

Review 1.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

2.  Puerarin ameliorates cognitive deficits in streptozotocin-induced diabetic rats.

Authors:  Xianchu Liu; Yanzhi Mo; Jingbo Gong; Zhuang Li; Huan Peng; Jiaxue Chen; Qichao Wang; Zhaowen Ke; Jingtao Xie
Journal:  Metab Brain Dis       Date:  2015-12-19       Impact factor: 3.584

3.  Effects of puerarin on lipid accumulation and metabolism in high-fat diet-fed mice.

Authors:  Guodong Zheng; Lezhen Lin; Shusheng Zhong; Qingfeng Zhang; Dongming Li
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

4.  Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways.

Authors:  Jie Liu; Wei Huang; Caiping Ren; Qiuyuan Wen; Weidong Liu; Xuyu Yang; Lei Wang; Bin Zhu; Liang Zeng; Xiangling Feng; Chang Zhang; Huan Chen; Wei Jia; Lihua Zhang; Xiaomeng Xia; Yuxiang Chen
Journal:  Sci Rep       Date:  2015-07-24       Impact factor: 4.379

5.  Puerarin Increases Survival and Protects Against Organ Injury by Suppressing NF-κB/JNK Signaling in Experimental Sepsis.

Authors:  Lei Wang; Qiao Liang; Anqi Lin; Xiufang Chen; Yongzhen Wu; Bin Zhang; Yu Zhang; Haiyan Min; Yanting Wen; Shiyu Song; Qian Gao
Journal:  Front Pharmacol       Date:  2020-05-07       Impact factor: 5.810

6.  Effect of Puerarin Regulated mTOR Signaling Pathway in Experimental Liver Injury.

Authors:  Bu-Gao Zhou; Hai-Mei Zhao; Xiu-Yun Lu; Wen Zhou; Fu-Chun Liu; Xue-Ke Liu; Duan-Yong Liu
Journal:  Front Pharmacol       Date:  2018-10-23       Impact factor: 5.810

Review 7.  Protective effect of isoflavones and triterpenoid saponins from pueraria lobata on liver diseases: A review.

Authors:  Heng He; Shuwei Peng; Xu Song; Renyong Jia; Yuanfeng Zou; Lixia Li; Zhongqiong Yin
Journal:  Food Sci Nutr       Date:  2021-12-10       Impact factor: 2.863

8.  Glycogen Synthase Kinase 3β inhibits BMSCs Chondrogenesis in Inflammation via the Cross-Reaction between NF-κB and β-Catenin in the Nucleus.

Authors:  Zhenggang Wang; Zhiyi He; Weikai Zhang; Shuang Liang; Kun Chen; Shimeng Xu; Ying Zhang; Peng Cheng
Journal:  Stem Cells Int       Date:  2022-09-12       Impact factor: 5.131

Review 9.  Natural Compounds: A Potential Treatment for Alcoholic Liver Disease?

Authors:  Junbin Yan; Yunmeng Nie; Minmin Luo; Zhiyun Chen; Beihui He
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.